Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 13, 2019
Amneal Pharmaceuticals is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level.
read more
Friday, November 08, 2019
Thermo Fisher Scientific is investing nearly $24 million in its Inchinnan, Scotland, site.
read more
Friday, November 08, 2019
IDT Biologika announced the NIAID of the NIH has awarded the company a new Task Order within the 10-year IDIQ to provide process development activities and production of a vaccine against the RSV.
read more
Thursday, November 07, 2019
Grand River Aseptic Manufacturing announced the addition of David Powell to its executive team.
read more
Thursday, November 07, 2019
ANI Pharmaceuticals announced its partner Pii has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection.
read more
Thursday, November 07, 2019
Bio-Techne announced a commitment to invest between $40 million and $50 million to expand its GMP-grade protein production capacity.
read more
Wednesday, November 06, 2019
Rentschler Biopharma SE is taking the first step in the expansion project to grow its U.S. footprint and establish a Center of Excellence in North America.
read more
Wednesday, November 06, 2019
Samsung Bioepis has entered into a new commercialization agreement with Biogen for two biosimilar candidates under development by Samsung Bioepis, SB11 (ranibizumab) and SB15 (aflibercept).
read more
Monday, November 04, 2019
Cosette Pharmaceuticals has purchased G&W Laboratories' finished dosage manufacturing plant located in Lincolnton, NC.
read more
Wednesday, October 30, 2019
The FDA issued a revised final guidance in January 2017, Guidance for Industry, Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act, which is in place while the FDA develops the 503B...
read more
Tuesday, October 29, 2019
One of the FDA's top priorities is to ensure that Americans have access to safe and effective medicines.
read more
Rentschler Biopharma announced Prof. Dr. Nikolaus F. Rentschler, and CEO Dr. Frank Mathias have received the "EY Entrepreneur of the Year" Award 2019 in the category Industry.
read more
Sterling Pharma Solutions, is investing $1.5 million into a phased expansion of its US facility in North Carolina.
read more
STA Pharmaceutical announced its Jinshan manufacturing facility in Shanghai, China has successfully passed an inspection by the EMA with no critical and no major findings.
read more
Phillips-Medisize announced an agreement with a leading biotechnology company to manufacture a wearable, electronic-enabled combination product.
read more